ABOUT US

We are a forward-thinking, mid-size early phase contract research organization, in Canada and the U.S., offering biopharmaceutical companies of all sizes a proven, flexible approach to early drug development, including preclinical safety testing, clinical pharmacology (Phase I to Phase II), bioanalysis (preclinical to Phase IV), research services, and manufacturing and analytical services. Focused on your success … always available and always looking ahead. Moving in unison to deliver big impact with a personal touch.

More About Us

...working with Altasciences has been excellent, from both a bioanalytical, and a bioavailability study perspective. We are really impressed with their planning and execution abilities – I would not consider another provider for future work.

James M Mackay, President and Chief Executive Officer, Aristea Therapeutics

RESOURCE CENTER

Blog - Protocol Design Concepts in Phase I Ethnobridging Clinical Trials

Read the blog

Protocol Design Concepts in Phase I Ethnobridging Clinical Trials

In Phase I ethnobridging clinical trials, there are three primary protocol design concepts utilized. These concepts align the strategy with global clinical development and measure key factors necessary for meeting the unique needs of the Sponsor.

View All News & Events Go to Resource Center

SELECT A CATEGORY BELOW:

The Altascientist Scientific journal
E-Bulletins Highlights on key topics
Newsletters Latest industry and corporate news
Scientific Publications Posters, case studies and abstracts
Blog
Videos

Careers

Join our team! Work at Altasciences - View all clinical job postings

Bring your talents and forward-thinking approach to Altasciences and help us develop medicines for those who need them, faster. We have a number of opportunities for you to explore.

Learn More

NEWS & EVENTS

A starry night with chemical-like webbing and the words "Altasciences Acquires WCCT Global" written over top.

Press Release

Altasciences Acquires WCCT Global

Altasciences is expanding its current clinical operations in Montreal and Kansas City with the addition of a clinical CRO on the U.S.A.'s West Coast. Click below to read more about the acquisition of WCCT Global.

View All News & Events Go to Resource Center

SELECT A CATEGORY BELOW:

Altasciences Events
Press Releases
Altasciences in the News
Press Kit
Webinars / Podcasts

Our Solutions

TESTIMONIALS

Find out what companies around the world are saying about working with Altasciences.

Aristea logo testimonial

Altasciences Full-Service Clinical Trial and Bioanalytical Support



We had the pleasure of working with the Altasciences team on a relative…

Chondrial logo

Re: IND-enabling bioanalytical support provided by Altasciences

We were very pleased with the way the team at Altasciences negotiated the…

Appili Therapeutics Logo

RE: Testimonial: Mitra® work provided by Altasciences…

Tetra Bio Pharma

Re: Altasciences [Double-Blind Phase I Study to Assess Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of cannabinoids by Inhalation…

Locemia Solutions Logo

We have retained the services of Algorithme Pharma (now Altasciences) since 2011 to perform a series of studies ranging from Phase I to Phase III…

gIcare pharma inc logo

Algorithme Pharma (now Altasciences) has been a great partner for us, in the context of key clinical trials for our lead drug candidates. The…

IDENIX logo

I am writing to recommend the services of Algorithme Pharma (now Altasciences). I have been using Algorithme Pharma (now Altasciences)…

Ethypharm logo

Algorithme Pharma (now Altasciences) has been a great partner of ours over the years, in performing Phase I studies in healthy volunteers.…

Isis Ionis Pharmaceuticals Logo

I am writing to recommend the services of Algorithme Pharma (now Altasciences), with whom Isis Pharmaceuticals Inc. (now Ionis) have partnered to…

2021 © Altasciences. All Rights Reserved.

Cookie Policy | Privacy Policy